ChemoMetec A/S (CHY) Stock Statistics & Valuation Metrics

ChemoMetec A/S has a market cap or net worth of €1.58B. The enterprise value is €9.84B.

ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

ChemoMetec A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 28.10%.

The current PE Ratio of ChemoMetec A/S is 63.1. ChemoMetec A/S’s PEG ratio is ―.

In the last 12 months, ChemoMetec A/S had revenue of 495.57M and earned 186.41M in profits. Earnings per share was 10.71.

In the last 12 months, operating cash flow was 207.45M and capital expenditures -29.87M, giving a free cash flow of 177.58M billion.

ChemoMetec A/S pays an annual dividend of ―, resulting in a dividend yield of ―

ChemoMetec A/S upcoming earnings date is Nov 11, 2025, TBA (Not Confirmed).

ChemoMetec A/S as a current ratio of 3.70, with Debt / Equity ratio of 1.30%

In the past 12 months, ChemoMetec A/S has paid 53.61M in taxes.

ChemoMetec A/S EV to EBITDA ratio is 39.72, with an EV/FCF ratio of 55.40.

ChemoMetec A/S has €341.85M in cash and marketable securities with €7.78M in debt, giving a net cash position of €335.44M billion.

Gross margin is 91.07%, with operating margin of 49.98%, and net profit margin of 37.61%.

The average price target for ChemoMetec A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―